ABSIEVE Trademark

Trademark Overview


On Monday, April 11, 2016, a trademark application was filed for ABSIEVE with the United States Patent and Trademark Office. The USPTO has given the ABSIEVE trademark a serial number of 86970797. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2017. This trademark is owned by AbCheck s.r.o.. The ABSIEVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for identification and characterization of binding molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and rese...
absieve

General Information


Serial Number86970797
Word MarkABSIEVE
Filing DateMonday, April 11, 2016
Status700 - REGISTERED
Status DateTuesday, August 15, 2017
Registration Number5263476
Registration DateTuesday, August 15, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements


Goods and ServicesScientific and technological services and research projects for the preparation of peptide and antibody libraries, and for identification and characterization of binding molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to antibody discovery, namely, scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to screening of antibody libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research and analysis in the field of antibody research and drug design

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 15, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbCheck s.r.o.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Party NameAbCheck s.r.o.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Party NameAbCheck s.r.o.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Trademark Events


Event DateEvent Description
Thursday, April 14, 2016NEW APPLICATION ENTERED
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2016ASSIGNED TO EXAMINER
Friday, July 29, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 29, 2016PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, August 2, 2016NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 16, 2017ASSIGNED TO LIE
Friday, February 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2017NON-FINAL ACTION WRITTEN
Thursday, March 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2017NON-FINAL ACTION E-MAILED
Wednesday, April 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 25, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 8, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, August 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL